Boston Scientific Corporation: Prostatic Hyperplasia trials

The registry lists 11 Prostatic Hyperplasia studies with Boston Scientific Corporation as lead sponsor. 1 are open to participants now and 7 have results posted.

No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Sacral Neuromodulation for Male Overactive Bladder (MOAB)RecruitingNCT06511141Not applicable
• Flexiva Pulse RegistryCompletedNCT05027971Results posted
• To Evaluate the Feasibility, Preliminary Safety and Performance of Rezūm System in BPH Treatment in ChinaCompletedNCT04823221Results posted
• Rezum I Pilot Study for Benign Prostatic HyperplasiaCompletedNCT02943070Not applicableResults posted
• Rezum FIM Optimization StudyCompletedNCT02940392Not applicableResults posted
• GreenLight XPS Laser System Retrospective Chart ReviewCompletedNCT02139969Results posted
• Safety and Efficacy Study for the Treatment of BPH (Enlarged Prostate)CompletedNCT01912339Not applicableResults posted
• Photoselective Vaporization of the Prostate With the GreenLight XPS™ Laser System vs TURP for the Treatment of BPHCompletedNCT01218672Not applicableResults posted
• Stone and Laser Therapies Post-Market Study (SALT)Active, not recruitingNCT06982235
• REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active MenActive, not recruitingNCT04838769Not applicable
• China Greenlight Registry Study (Post-market)CompletedNCT03736512